Multiple sclerosis: open trials in France

• NCT06161376

  Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis

  Research · University Hospital, Toulouse

  Toulouse Hospital, Toulouse

  Registry updated 2025-12-31

• NCT04573673

  Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.

  Trial Treatment · University Hospital, Lille

  Hop Claude Huriez Chu Lille, Lille

  Registry updated 2025-12-23

• NCT05633875

  Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis

  Research · Assistance Publique - Hôpitaux de Paris

  CIC Neurosciences, Paris

  Registry updated 2025-12-09

• NCT07245589

  Evaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging

  Trial Treatment · Assistance Publique Hopitaux De Marseille

  Hôpital Gui de Chauliac, Montpellier

  Registry updated 2025-11-24

• NCT06426316

  The Role of Cytokines and Regulatory T Lymphocytes in Migraine Pathophysiology.

  Trial Treatment · University Hospital, Clermont-Ferrand

  CHU de Clermont-Ferrand - Service de Neurologie, Clermont-Ferrand

  Registry updated 2025-11-20

• NCT07202494

  Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

  Research · Assistance Publique Hopitaux De Marseille

  Chu Timone, Marseille

  Registry updated 2025-10-01

• NCT07108920

  Analysis of Balance Disorders After Botulinum Toxin Treatment in the Rectus Femoris in Patients With a Stiff Knee Gait

  Research · Hopital Nord Franche-Comte

  Centre de Médecine Physique et de Réadaptation Bretegnier, Héricourt

  Registry updated 2025-09-22

• NCT05962177

  Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic

  Trial Treatment · University Hospital, Montpellier

  Neurology Department, Hopital Gui de Chauliac, Montpellier

  Registry updated 2025-09-16

• NCT04694534

  Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients

  Trial Treatment · Lille Catholic University

  CH Arras, Arras · CH Lens, Lens · CHRU, Lille · Saint Vincent hospital, Lille · Saint-Philibert hospital, Lomme · Charles Nicolle Hospital, Rouen

  Registry updated 2025-09-04

• NCT06455332

  Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome

  Trial Treatment · University Hospital, Lille

  Hopital Roger Salengro, Lille

  Registry updated 2025-08-24

• NCT03910738

  TOTEM RRMS : TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis

  Trial Treatment · Phase 2 · University Hospital, Strasbourg, France

  Centre Hospitalier Regional Universitaire, Besancon Cedex · CHRU de Nancy, Nancy · Assistance Publique Hopitaux De Paris, Paris Cedex 13 · Centre Hospitalier Universitaire De Rennes, Rennes Cedex 9 · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2

  Registry updated 2025-06-29

• NCT05227092

  3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

  Trial Treatment · University Hospital, Bordeaux

  CHU de Bordeaux, Bordeaux

  Registry updated 2025-06-29

• NCT07030036

  Screening for Cognitive Disorders in Multiple Sclerosis

  Research · Centre Hospitalier de Gonesse

  France, Gonesse

  Registry updated 2025-06-19

• NCT06994026

  Feasibility Study of a Relapse Investigation Questionnaire Administered by an MS Care Coordinator Nurse in Patients With Multiple Sclerosis

  Research · Centre Hospitalier de Gonesse

  France, Gonesse

  Registry updated 2025-05-29

• NCT06920524

  Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT)

  Trial Treatment · University Hospital, Clermont-Ferrand

  CHU de Clermont-Ferrand, Clermont-Ferrand

  Registry updated 2025-05-23

• NCT02912897

  Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple Sclerosis

  Trial Treatment · Phase 1 · Nantes University Hospital

  Centre Hospitalier Universitaire de Nantes, Saint-Herblain

  Registry updated 2025-02-19

• NCT06663189

  Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)

  Trial Treatment · Phase 3 · University Hospital, Strasbourg, France

  Centre hospitalier Universitaire de Bordeaux, Bordeaux · Centre Hospitalier Universitaire De Caen Normandie, Caen Cedex 9 · Centre Jean Perrin, Clermont-Ferrand · Assistance Publique Hopitaux De Paris, Creteil Cedex · Centre Hospitalier Universitaire de Dijon, Dijon · Centre Hospitalier General, Gonesse · CHD Vendée, La Roche-sur-Yon · Centre Hospitalier Universitaire Grenoble Alpes, La Tronche · Centre Hospitalier Universitaire De Lille, Lille Cedex · Groupement Des Hopitaux De L'Institut Catholique De Lille, Lille Cedex · Centre Hospitalier Et Universitaire De Limoges, Limoges Cedex 1 · Centre Hospitalier Regional De Marseille, Marseille · Centre Hospitalier Universitaire De Montpellier, Montpellier Cedex 5 · CHRU de Nancy, Nancy · Centre Hospitalier Universitaire de Nice, Nice · Centre Hospitalier Universitaire De Nimes, Nimes Cedex 9 · Fondation A. de Rothschild, Paris · Assistance Publique Hopitaux de Paris, Paris · Centre Hospitalier Universitaire de Rennes, Rennes · Centre Hospitalier Universitaire Rouen, Rouen Cedex · Centre Hospitalier Universitaire de Nantes, Saint-Herblain · Les Hopitaux Universitaires De Strasbourg, Strasbourg Cedex 2 · Centre Hospitalier Regional Universitaire De Tours, Tours Cedex 9

  Registry updated 2025-01-03

• NCT06330077

  Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

  Trial Treatment · Phase 2 · Assistance Publique - Hôpitaux de Paris

  Hôpital Neurologique Pierre WERTHEIMER - HCL, Bron · Groupe Hospitalier Pitié Salpêtrière - APHP, Paris

  Registry updated 2024-03-26

• NCT02883335

  Lorraine Registry of Multiple Sclerosis

  Research · Central Hospital, Nancy, France

  CIC 1433 Épidémiologie clinique, Inserm, Université de Lorraine, CHRU de Nancy, Nancy

  Registry updated 2023-02-08

• NCT05388331

  RIS International Cohort

  Research · Centre Hospitalier Universitaire de Nice

  Nice University Hospital, Nice

  Registry updated 2022-05-24

All Multiple sclerosis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error